Literature DB >> 23093274

Association of acute phase protein-haptoglobin, and epithelial-mesenchymal transition in buccal cancer: a preliminary report.

Ching-Chih Lee1, Hsu-Chueh Ho, Sou-Hsin Chien, Shih-Hsuan Hsiao, Shih-Kai Hung, Tze-Ta Huang, Chih-Chia Yu, Shu-Mei Chang, Huai-Huei Huang, Yu-Chieh Su.   

Abstract

BACKGROUND: The aim of this study was to determine the influence of inflammation on acute phase protein and epithelial-mesenchymal transition (EMT) in buccal cancer.
METHODS: Western blotting was carried out to investigate the expression of haptoglobin and epithelial-mesenchymal transition in oral cancer cell lines with or without IL-6 stimulation. We studied patients with buccal cancer patients without distant metastasis at diagnosis. Correlation between cellular haptoglobin, EMT, and clinical characteristics of buccal cancer was analyzed to assess the prognostic value of cellular haptoglobin level and EMT. The relationship of haptoglobin, and EMT expression with survival was assessed using Cox proportional hazard models.
RESULTS: Western blotting analysis showed that increased haptoglobin protein was associated with overexpression of vimentin. Under IL-6 stimulation, overexpression of haptoglobin, EMT-associated motile phenotype was noted in OC2 cell lines. Overexpression of haptoglobin was also associated with an increased risk for locoregional recurrence [hazard ratio (HR) 1.04; p=0.011] after adjusting for age, gender, disease site, stage, and treatment modality.
CONCLUSIONS: Increased cellular expression of haptoglobin is associated with EMT in oral cancer cell lines and this phenomenon could be exaggerated with IL-6. Cellular expression of haptoglobin is related to locoregional recurrence rate in buccal cancer patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23093274     DOI: 10.1515/cclm-2012-0197

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  4 in total

1.  High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer.

Authors:  Jianjun Lu; Yanhong Wang; Miansheng Yan; Pinning Feng; Linjing Yuan; Yuesu Cai; Xin Xia; Min Liu; Jinmei Luo; Laisheng Li
Journal:  Oncotarget       Date:  2016-07-05

2.  Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.

Authors:  Chun-San Tai; Yan-Ren Lin; Tsung-Han Teng; Ping-Yi Lin; Siang-Jyun Tu; Chih-Hung Chou; Ya-Rong Huang; Wei-Chih Huang; Shun-Long Weng; Hsien-Da Huang; Yao-Li Chen; Wen Liang Chen
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

3.  Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.

Authors:  Mi-Kyung Oh; Hansol Joo; In-Sook Kim
Journal:  PLoS One       Date:  2022-05-17       Impact factor: 3.240

4.  Haptoglobin and CCR2 receptor expression in ovarian cancer cells that were exposed to ascitic fluid: exploring a new role of haptoglobin in the tumoral microenvironment.

Authors:  O L Garibay-Cerdenares; V I Hernández-Ramírez; J C Osorio-Trujillo; D Gallardo-Rincón; P Talamás-Rohana
Journal:  Cell Adh Migr       Date:  2015-07-25       Impact factor: 3.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.